AtlasXomics
New Haven, US · Founded 2020 · Delaware corporation · 1 known investors
AtlasXomics develops spatial epigenomics tools, spanning chip fabrication, hardware, and bioinformatics, for researchers studying areas such as cancer and systems biology. The company serves scientific and clinical research customers with technology for analyzing epigenetic regulation.
Founders & leadership
GH
Gregory HoNamed on SEC filing
RA
Richard AnderssonNamed on SEC filing
Board
KW
Kenneth WangInvestor and entrepreneur (board member)
Investors · 1
Reported raises · per SEC filings
Form D private placements$6.2M disclosed across 3 rounds · 2020–2021
▶$3.9MraisedJan 2022 · 4 investors · BiotechnologyRule 506(b)
▶$3.9MraisedJan 2022 · 4 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Richard AnderssonDirector
- John SteffensDirector
- Kenneth WangExecutive Officer, Director
- Gregory HoDirector
- Offering amount
- $8M
- Amount sold
- $3.9M
- First sale
- Dec 2021
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$1.8MraisedMar 2021 · 1 investors · BiotechnologyRule 506(b)
▶$1.8MraisedMar 2021 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Kenneth WangExecutive Officer, Director
- Gregory HoDirector
- Richard AnderssonDirector
- John SteffensDirector
- Offering amount
- $3.5M
- Amount sold
- $1.8M
- First sale
- Feb 2021
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$470KraisedJun 2020 · 2 investors · BiotechnologyRule 506(b)
▶$470KraisedJun 2020 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Gregory HoDirector
- Richard AnderssonDirector
- Kenneth WangExecutive Officer, Director
- Offering amount
- $1.3M
- Amount sold
- $470K
- Minimum investment
- $25K
- First sale
- May 2020
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 5
by search overlap10x Genomics 1-color19 shared keywords10x Genomics offers single cell analysis technology, including its Flex assay and Flex Apex product, which use probe-based chemistry and plate-based multiplexing to profile fresh, frozen, and FFPE samples for researchers. The tools support applications in cancer, immunology, and neuroscience, enabling gene expression and multiomic profiling of cell surface protein, intracellular protein, and CRISPR guides.
IDbyDNA16 shared keywordsScalable, high throughput DNA sequencing platforms.
Active Motif12 shared keywords
Oup12 shared keywordsOxford University Press publishes research, educational, and reference materials, including reports on reading and children's learning, and reference resources such as its dictionary "Word of the Day." It serves readers, educators, and learners across a wide range of subjects worldwide.
LatchBio11 shared keywordsLatch builds data infrastructure and software tools for biological computing, enabling researchers to program and automate biological discovery through high-throughput laboratory automation and machine learning.
Companies competing with AtlasXomics for the same Google search keywords, organic and paid, via search-intersection analysis.
Non-dilutive funding · 3 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2023 | $1.4M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2022 | $251.1K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2022 | $222K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
In the news
Frequently asked questions
- What does AtlasXomics do?
- AtlasXomics develops spatial epigenomics tools, spanning chip fabrication, hardware, and bioinformatics, for researchers studying areas such as cancer and systems biology. The company serves scientific and clinical research customers with technology for analyzing epigenetic regulation.
- Who are AtlasXomics's investors?
- AtlasXomics's investors include Connecticut Innovations.
- How much funding has AtlasXomics raised?
- AtlasXomics has disclosed $6.2M raised across 3 rounds.
- Where is AtlasXomics headquartered?
- AtlasXomics is headquartered in New Haven, US.